The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics

Laura C Coates, William Tillett, David Chandler, Philip S Helliwell, Eleanor Korendowych, Stuart Kyle, Iain B McInnes, Susan Oliver, Anthony Ormerod, Catherine Smith, Deborah Symmons, Nicola Waldron, Neil J McHugh, BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR

Research output: Contribution to journalArticle

59 Citations (Scopus)
Original languageEnglish
Pages (from-to)1754-1757
Number of pages4
JournalRheumatology
Volume52
Issue number10
Early online date25 Jul 2013
DOIs
Publication statusPublished - Oct 2013

Keywords

  • algorithms
  • antirheumatic agents
  • arthritis, psoriatic
  • biological products
  • humans
  • treatment failure
  • tumor necrosis factor-alpha
  • biologics
  • treatment
  • management
  • guidelines
  • recommendations
  • anti-TNF therapies
  • psoriasis
  • enthesitis
  • dactylitis

Cite this

Coates, L. C., Tillett, W., Chandler, D., Helliwell, P. S., Korendowych, E., Kyle, S., ... BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR (2013). The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. Rheumatology, 52(10), 1754-1757. https://doi.org/10.1093/rheumatology/ket187